BR100 Decreased By (-0.57%)
BR30 Decreased By (-0.83%)
KSE100 Decreased By (-0.48%)
KSE30 Decreased By (-0.41%)
AGHA 6.62 Decreased By ▼ -0.05 (-0.75%)
BECO 4.40 Increased By ▲ 0.05 (1.15%)
BML 55.05 Decreased By ▼ -1.12 (-1.99%)
BOP 29.98 Decreased By ▼ -0.14 (-0.46%)
CNERGY 12.76 Decreased By ▼ -0.22 (-1.69%)
CSIL 5.19 Decreased By ▼ -0.12 (-2.26%)
FCCL 51.05 Decreased By ▼ -0.60 (-1.16%)
FFL 14.45 Decreased By ▼ -0.04 (-0.28%)
FNEL 1.21 No Change ▼ 0.00 (0%)
KEL 6.03 Decreased By ▼ -0.03 (-0.5%)
KOSM 5.59 Decreased By ▼ -0.25 (-4.28%)
LOTCHEM 26.08 Decreased By ▼ -0.09 (-0.34%)
MLCF 89.67 Decreased By ▼ -1.56 (-1.71%)
NBP 162.15 Decreased By ▼ -2.04 (-1.24%)
NCPL 52.45 Decreased By ▼ -0.73 (-1.37%)
NPL 57.80 Decreased By ▼ -1.32 (-2.23%)
OGDC 312.98 Decreased By ▼ -0.41 (-0.13%)
PACE 9.69 Decreased By ▼ -0.08 (-0.82%)
PAEL 34.95 Decreased By ▼ -0.29 (-0.82%)
PIBTL 14.36 Decreased By ▼ -0.35 (-2.38%)
PPL 218.98 Decreased By ▼ -2.38 (-1.08%)
PRL 91.58 Increased By ▲ 0.36 (0.39%)
PTC 59.00 Decreased By ▼ -0.19 (-0.32%)
SSGC 23.33 Increased By ▲ 0.03 (0.13%)
TBL 8.66 Decreased By ▼ -0.09 (-1.03%)
TELE 7.47 Decreased By ▼ -0.14 (-1.84%)
TPL 21.30 Decreased By ▼ -0.73 (-3.31%)
TPLP 12.15 Decreased By ▼ -0.41 (-3.26%)
TREET 21.60 Decreased By ▼ -0.13 (-0.6%)
TRG 55.10 Decreased By ▼ -0.69 (-1.24%)

ISLAMABAD: The Competition Commission of Pakistan (CCP) has granted approval for the acquisition of a certain shareholding in Route2Health (Private) Limited by AZT Foundation from Tausif Ahmad Khan, Zainub Abbas, and Javaid Hussain, under a Share Purchase Agreement.

AZT Foundation, a UAE-based organization, was established for the purpose of holding and managing the assets on behalf of the aforementioned individuals (sellers). Route2Health (Pvt) Limited is engaged in the business of manufacturing, marketing, and distribution of nutraceuticals and health supplements in Pakistan.

Following a detailed competitive analysis, the CCP identified the relevant product market as ‘Nutraceutical and Herbal Supplements’. The transaction has been classified as a conglomerate merger, as there are no horizontal or vertical overlaps between the acquirer and the target.

The Commission concluded that the transaction would not result in the creation or strengthening of a dominant position in the relevant market. Hence, the CCP has approved the transaction in accordance with Section 11 of the Competition Act, 2010.

Copyright Business Recorder, 2025

Comments

Comments are closed for this article.